PubRank

Keith Grimwood

Author PubWeight™ 66.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet 2005 3.01
2 Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med 2002 2.38
3 Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009 1.97
4 Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005 1.90
5 Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011 1.72
6 Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. JAMA 2011 1.68
7 Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust 2010 1.66
8 Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples. PLoS One 2012 1.44
9 Energy metabolism in infants with cystic fibrosis. J Pediatr 2002 1.40
10 Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002 1.38
11 Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012 1.37
12 Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010 1.30
13 Respiratory bacterial pathogens in the nasopharynx and lower airways of Australian indigenous children with bronchiectasis. J Pediatr 2010 1.29
14 Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J Clin Microbiol 2010 1.21
15 Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 2012 1.17
16 The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J 2013 1.15
17 Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. Am J Respir Crit Care Med 2005 1.15
18 Emergence of echovirus type 13 as a prominent enterovirus. Clin Infect Dis 2003 1.13
19 Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. J Med Virol 2006 1.10
20 Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis. PLoS One 2013 0.99
21 The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party. N Z Med J 2004 0.98
22 Observational Research in Childhood Infectious Diseases (ORChID): a dynamic birth cohort study. BMJ Open 2012 0.97
23 Absence of an important vaccine and diagnostic target in carriage- and disease-related nontypeable Haemophilus influenzae. Clin Vaccine Immunol 2013 0.97
24 Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 2009 0.95
25 Nasal swab samples and real-time polymerase chain reaction assays in community-based, longitudinal studies of respiratory viruses: the importance of sample integrity and quality control. BMC Infect Dis 2014 0.95
26 Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients. Clin Chem 2007 0.94
27 Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol 2011 0.94
28 Acquisition of human polyomaviruses in the first 18 months of life. Emerg Infect Dis 2015 0.94
29 Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 2012 0.92
30 Infants hospitalised with pertussis: estimating the true disease burden. J Paediatr Child Health 2007 0.91
31 Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol 2013 0.91
32 Cognitive and executive function 12 years after childhood bacterial meningitis: effect of acute neurologic complications and age of onset. J Pediatr Psychol 2004 0.90
33 Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines 2014 0.89
34 Clonal complex Pseudomonas aeruginosa in horses. Vet Microbiol 2010 0.88
35 Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities. Med J Aust 2008 0.87
36 Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 2013 0.87
37 Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol. Trials 2011 0.85
38 Flexible bronchoscopy in managing a child with pulmonary hydatid disease. Pediatr Pulmonol 2012 0.85
39 Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis. Thorax 2010 0.85
40 Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis. Pediatr Pulmonol 2012 0.85
41 Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials 2013 0.84
42 Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value Health 2009 0.84
43 A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis. BMC Infect Dis 2014 0.82
44 Awareness, knowledge and attitudes of lead maternity carers towards early-onset neonatal group B streptococcal disease. N Z Med J 2002 0.82
45 Time course of transient cortical scintigraphic defects associated with acute pyelonephritis. Pediatr Radiol 2002 0.81
46 Prevention of neonatal group B streptococcus disease in the 21st century. J Paediatr Child Health 2011 0.80
47 High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform. J Med Microbiol 2013 0.80
48 Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial. BMC Pediatr 2012 0.79
49 Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. Trials 2012 0.79
50 Persistent renal cortical scintigram defects in children 2 years after urinary tract infection. Pediatr Radiol 2004 0.78
51 Should rotavirus vaccines be included in the national immunization program of a small developed country? Expert Rev Pharmacoecon Outcomes Res 2009 0.78
52 An echovirus type 33 winter outbreak in New Zealand. Clin Infect Dis 2003 0.78
53 Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates. Aust N Z J Obstet Gynaecol 2011 0.77
54 Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection. Hum Vaccin Immunother 2012 0.77
55 Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Chest 2014 0.77
56 Nocardia brasiliensis infection mimicking juvenile idiopathic arthritis in a 4-year-old girl. Pediatrics 2013 0.77
57 Community-associated methicillin-resistant Staphylococcus aureus causing orbital cellulitis in Australian children. Pediatr Infect Dis J 2011 0.76
58 A retrospective performance evaluation of an adenovirus real-time PCR assay. J Med Virol 2013 0.76
59 Human bocavirus in infants, New Zealand. Emerg Infect Dis 2007 0.76
60 Geographical differences in the proportion of human group A rotavirus strains within New Zealand during one epidemic season. J Med Virol 2010 0.76
61 Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations. Expert Rev Respir Med 2013 0.76
62 Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012 0.76
63 Quantitative PCR confirms culture as the gold standard for detection of lower airway infection by nontypeable Haemophilus influenzae in Australian Indigenous children with bronchiectasis. J Microbiol Methods 2012 0.75
64 Active surveillance of serious adverse drug reactions in New Zealand children. Arch Dis Child 2012 0.75
65 Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. Trials 2013 0.75
66 Canadian rotavirus vaccine effectiveness data. Can Fam Physician 2012 0.75
67 Saksenaeae Subcutaneous Abscess in an Immunocompetent Child. Pediatr Infect Dis J 2016 0.75
68 Parainfluenza Virus Infection in an Australian Community-based Birth Cohort. Pediatr Infect Dis J 2020 0.75
69 Early-onset group B streptococcus prevention protocols in New Zealand public hospitals. Aust N Z J Obstet Gynaecol 2002 0.75
70 Operative rates for acute intussusception in New Zealand. N Z Med J 2004 0.75
71 Mycoplasma pneumoniae infection complicated by pneumomediastinum and severe mucositis. J Paediatr Child Health 2007 0.75
72 Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatr Pulmonol 2008 0.75
73 Respiratory Viruses in Neonates: A Prospective, Community-based Birth Cohort Study. Pediatr Infect Dis J 2016 0.75